Skip to main content
Clinical Trials/TCTR20230212003
TCTR20230212003
Recruiting
Phase 4

The study to evaluate the efficacy and safety of using Platelet-rich plasma combined with hyaluronic acid for treating neck rejuvenation in Thailand.

ASTRACO MEDICAL NETWORKS LTD.0 sites32 target enrollmentFebruary 12, 2023

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Healthy
Sponsor
ASTRACO MEDICAL NETWORKS LTD.
Enrollment
32
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 12, 2023
End Date
September 17, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
ASTRACO MEDICAL NETWORKS LTD.

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 30\-60 years old
  • 2\. Both male and female
  • 3\. Neck laxity grade 1\-5 from Wrinkle Assessment Scale of horizontal neck folds

Exclusion Criteria

  • 1\. Subjects who are pregnant
  • 2\. Subjects who had history of low platelet, coagulopathy or taking medicine of antocoagulant drug like warfarin
  • 3\. Subjects who has dermatits, wound or infection at treatment area
  • 4\. Subjects who allergy to anesthesia cream
  • 5\. Subjects who taken oral or injection contraceptive pills
  • 6\. Subjects who had history of laser at treatment area within 6 months before arrived the project 7\. Subjects who had history of keloid or hypertrophic scar
  • 8\. Subjects who had history of psychitic disease

Outcomes

Primary Outcomes

Not specified

Similar Trials